InMed Pharmaceuticals Inc. INM
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.59M | -5.54M | -5.54M | -6.09M | -6.04M |
| Total Depreciation and Amortization | 574.90K | 443.40K | 443.40K | 414.50K | 402.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.96M | -575.90K | -575.90K | -634.90K | -622.30K |
| Change in Net Operating Assets | 107.60K | -418.80K | -418.80K | 90.10K | -179.10K |
| Cash from Operations | -6.95M | -6.09M | -7.75M | -7.88M | -8.10M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 3.77M | 3.77M | 4.17M | 5.20M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -137.20K | 4.27M | 4.27M | 4.21M | 4.16M |
| Cash from Financing | -137.20K | 8.04M | 10.96M | 11.30M | 12.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.09M | 1.94M | 3.20M | 3.42M | 4.17M |